Logo image of CHWA

CHW ACQUISITION CORP (CHWA) Stock Fundamental Analysis

NASDAQ:CHWA - Nasdaq - KYG2254A1094 - Common Stock - Currency: USD

8.28  +0.51 (+6.56%)

After market: 8.02 -0.26 (-3.14%)

Fundamental Rating

1

Overall CHWA gets a fundamental rating of 1 out of 10. We evaluated CHWA against 0 industry peers in the Unkown industry. CHWA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. CHWA has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year CHWA has reported negative net income.
CHWA Yearly Net Income VS EBIT VS OCF VS FCFCHWA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 -200K -400K -600K -800K

1.2 Ratios

Industry RankSector Rank
ROA -2.38%
ROE N/A
ROIC -1.93%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CHWA Yearly ROA, ROE, ROICCHWA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 -0.2 -0.4 -0.6

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for CHWA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CHWA Yearly Profit, Operating, Gross MarginsCHWA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021

More info and screens

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CHWA is destroying value.
CHWA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CHWA Yearly Shares OutstandingCHWA Yearly Shares OutstandingYearly Shares Outstanding 2021 5M 10M 15M
CHWA Yearly Total Debt VS Total AssetsCHWA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 20M 40M 60M 80M 100M

2.2 Solvency

An Altman-Z score of 4.47 indicates that CHWA is not in any danger for bankruptcy at the moment.
CHWA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 4.47
ROIC/WACC-0.22
WACC8.71%
CHWA Yearly LT Debt VS Equity VS FCFCHWA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 20M 40M 60M 80M 100M

2.3 Liquidity

CHWA has a Current Ratio of 0.31. This is a bad value and indicates that CHWA is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.31 indicates that CHWA may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.31
Quick Ratio 0.31
CHWA Yearly Current Assets VS Current LiabilitesCHWA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 200K 400K 600K 800K 1M

More info and screens

0

3. Growth

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CHWA Yearly Revenue VS EstimatesCHWA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021
CHWA Yearly EPS VS EstimatesCHWA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CHWA. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CHWA Price Earnings VS Forward Price EarningsCHWA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CHWA Per share dataCHWA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CHWA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CHW ACQUISITION CORP

NASDAQ:CHWA (8/9/2022, 8:00:00 PM)

After market: 8.02 -0.26 (-3.14%)

8.28

+0.51 (+6.56%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners1.7%
Inst Owner Change0%
Ins Owners76.38%
Ins Owner Change0%
Market Cap52.14M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.44
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.19
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS18.91
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.38%
ROE N/A
ROCE N/A
ROIC -1.93%
ROICexc N/A
ROICexgc -1.93%
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score0
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.31
Quick Ratio 0.31
Altman-Z 4.47
F-Score0
WACC8.71%
ROIC/WACC-0.22
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A